A Study of INCMGA00012 in Metastatic Merkel Cell CarcinomaResearch Question:
What is the clinical activity and safety of INCMGA00012 in participants with metastatic
merkel cell carcinoma (MCC)?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
The purpose of this study is to assess the clinical activity and safety of INCMGA00012,
a monoclonal antibody, in participants with metastatic merkel cell carcinoma (MCC).
Study Reference #: IMEL19023
Lead Researcher (Principal Investigator)
Lead Researcher: Adrienne Victor
Study Contact InformationStudy Coordinator: Park Bogan
Phone: (585) 276-4415
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search